Stem Cell Therapeutics Announces Closing Of $2.0 Million Unit Offering
Stem Cell Therapeutics Corp. ("SCT") (TSX VENTURE:SSS) has closed its previously announced $2.0 Million private placement of 10,000,000 units, each unit consisting of one common share of SCT and one-half of one common share purchase warrant. Each full warrant entitles the holder to purchase one additional common share of SCT for $0.25 until February 1, 2009.